Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Common Equity (2016 - 2025)

Historic Common Equity for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to $37.0 million.

  • Rockwell Medical's Common Equity rose 2706.37% to $37.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.0 million, marking a year-over-year increase of 2706.37%. This contributed to the annual value of $32.6 million for FY2024, which is 5305.06% up from last year.
  • According to the latest figures from Q3 2025, Rockwell Medical's Common Equity is $37.0 million, which was up 2706.37% from $30.4 million recorded in Q2 2025.
  • Over the past 5 years, Rockwell Medical's Common Equity peaked at $37.0 million during Q3 2025, and registered a low of -$4.8 million during Q1 2022.
  • In the last 5 years, Rockwell Medical's Common Equity had a median value of $20.6 million in 2024 and averaged $19.6 million.
  • Within the past 5 years, the most significant YoY rise in Rockwell Medical's Common Equity was 45644.97% (2022), while the steepest drop was 11834.73% (2022).
  • Quarter analysis of 5 years shows Rockwell Medical's Common Equity stood at $2.5 million in 2021, then soared by 456.45% to $14.1 million in 2022, then soared by 50.94% to $21.3 million in 2023, then skyrocketed by 53.05% to $32.6 million in 2024, then rose by 13.61% to $37.0 million in 2025.
  • Its Common Equity stands at $37.0 million for Q3 2025, versus $30.4 million for Q2 2025 and $31.5 million for Q1 2025.